Singapore’s loans growth stabilising
Latest statistics from MAS reported loans growth of 2.6% YoY for October, in line with YTD monthly average loans growth of 2.3% YoY. Business loans growth of 5.2% YoY offset some of the contraction in consumer loans growth of 1.2% (Figure 1). Building & construction loans (+6.4% YoY) held up growth due to the progressive drawdown of loans from existing projects in the pipeline. Consumer loans contracted for the seventh consecutive month, dragged by persistent weakness in housing loans contraction of 1.4% YoY due to property cooling measures. We expect loans growth for the Singapore banks to slow to 4-5% for FY20e due to dampened business sentiments from continued macroeconomic weakness.
Deposits – FD kept up the momentum while CASA growth recovered from contraction
In September, CASA growth continued its recovery to 1.4% YoY after contracting in the first half of 2019. FD kept up its strong momentum at 19.7% YoY in October, outpacing overall deposits growth of 8.5% YoY (Figure 2).
Following interest rates cuts in the U.S., banks in Singapore lowered their fixed deposit rates (Figure 3). We reiterate our expectations of easing competition for FD in 2020 due to further rate cut expectations and slower global economic growth. As the banks release excess FD, funding pressure should ease and offset some of the impact of lower interest rates.
Despite the recent Fed rate cuts and downward adjustments of FD rates, FD is still growing strongly. We believe that one of the reasons for sustained demand for FD was due to the saturation of appetite for Singapore Savings Bond (SSBs). The total amount applied for SSBs in November and October was S$44mn and S$51mn respectively, down from the peak of S$457mn in February and YTD average of S$252mn.
In addition, tight liquidity in the banking sector sustained the competition for deposits, making it difficult to lower FD rates too much in the near term. Hence investors would still opt for banks’ FD with higher rates (Figure 3) as compared to 1.56% for a 12 months tenure for SSBs.
3M SIBOR down 4bps MoM to 1.769%, while 3M SOR rose 2bps to 1.537%
Meanwhile, the savings rate in Singapore remained unchanged at 0.16% (Figure 5). The U.S. Federal Reserve’s easing monetary policy limits the upside for NIM expansion in FY20. However, as FD rates start to trend down due to slowing economic growth, lower funding costs could offset some of the impact of lower interest rates on NIM. Hence, we still expect the banks to deliver full-year NIM improvements due to the lagged effect of loan repricing, albeit at a lower magnitude of around 1-4 bps in FY19e.
Volatility – a favourable backdrop for derivatives
SGX’s October total derivatives volume fell 24% YoY, and Derivatives Daily Average Volume (DDAV) fell 22% YoY to 0.855mn. October saw lower volatility as compared to the two most volatile months (May and August) this year when Trump unleashed his tariff hikes, as evident in DDAV spiking 54% and 33% YoY respectively.
1Q20’s total derivative volume and DDAV grew 14% and 12% YoY respectively. Meanwhile, 1Q20 SDAV came in at S$1.062bn and its YoY growth recovered to -1% as compared to the quarterly average contraction of -16% YoY in FY19.
Besides benefiting from the occasional volatility due to trade tensions between the U.S. and China, the underlying growth in demand for derivatives will be sustained by increasing interconnectedness and globalisation of markets. SGX’s derivative products capture global flows and are not as reliant on local liquidity as the securities business.
Hong Kong’s loans growth inched higher at 7.0% YoY in October
Hong Kong’s loans grew at a respectable pace of 7.0% YoY despite high interest rates and lingering geopolitical tensions. Residential sales and purchase value in October rose 47% MoM and volumes grew 16% MoM. Home prices in Hong Kong recovered back to levels similar to a year ago (Figure 11). Meanwhile, 3-month HIBOR rose 19bps MoM to 2.355% (Figure 10).
Investment Actions
Maintain the Singapore Banking Sector at Overweight. The impact of the three interest rate cuts and slowdown in global economic growth should be offset by growth in fee income and other non-interest income from segments such as wealth management, deals and bonds. There is also a dividend yield support of c.5% for the sector.
Our top pick from the Singapore Banking Sector is UOB due to its (i) lowest exposure to Greater China and Hong Kong as compared to DBS and OCBC, (ii) low NIM sensitivity to falling interest rates, and (iii) defensive wealth management business which targets the mass affluent.
With the U.S. Federal Reserve’s easing monetary policy, we expect downside risks to NIM to be slightly offset by better deposits mix with the release of excess fixed deposits, lagged effect for loans to be repriced downwards and a potential rise in volumes.
Our recommendation will be subject to changes based on the following re-rating catalysts
|
Risks |
Upside |
|
(i) Miss in CIR % target due to higher spending on investments. (ii) Limited rise in interest rates and rising competition resulting in lower than expected NIM. (iii) Volatility leading to higher capital market-linked revenue losses. (iv) Changes in market-linked assumptions resulting in higher ECL. (v) Deterioration in portfolio quality. |
(i) Earlier than expected CIR % improvement with digitisation. (ii) Better credit quality leading to higher writebacks and recoveries. (iii) Stronger than expected growth in non-interest income revenue streams.
|
Important Information
This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE
Where the report contains research analyses or reports from a foreign research house, please note:
